PH12016500497B1 - Compositions for the treatment of hypertension and/or fibrosis - Google Patents

Compositions for the treatment of hypertension and/or fibrosis Download PDF

Info

Publication number
PH12016500497B1
PH12016500497B1 PH12016500497A PH12016500497A PH12016500497B1 PH 12016500497 B1 PH12016500497 B1 PH 12016500497B1 PH 12016500497 A PH12016500497 A PH 12016500497A PH 12016500497 A PH12016500497 A PH 12016500497A PH 12016500497 B1 PH12016500497 B1 PH 12016500497B1
Authority
PH
Philippines
Prior art keywords
fibrosis
compound
present
treatment
hypertension
Prior art date
Application number
PH12016500497A
Other languages
English (en)
Other versions
PH12016500497A1 (en
Inventor
Karen Annette Duggan
Original Assignee
Vectus Biosystems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903573A external-priority patent/AU2013903573A0/en
Application filed by Vectus Biosystems Ltd filed Critical Vectus Biosystems Ltd
Publication of PH12016500497A1 publication Critical patent/PH12016500497A1/en
Publication of PH12016500497B1 publication Critical patent/PH12016500497B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH12016500497A 2013-09-17 2016-03-14 Compositions for the treatment of hypertension and/or fibrosis PH12016500497B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013903573A AU2013903573A0 (en) 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis
PCT/AU2014/000923 WO2015039173A1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis

Publications (2)

Publication Number Publication Date
PH12016500497A1 PH12016500497A1 (en) 2016-06-13
PH12016500497B1 true PH12016500497B1 (en) 2017-12-13

Family

ID=52687998

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016500497A PH12016500497B1 (en) 2013-09-17 2016-03-14 Compositions for the treatment of hypertension and/or fibrosis

Country Status (22)

Country Link
US (1) US9458093B2 (cg-RX-API-DMAC10.html)
EP (1) EP3046901B1 (cg-RX-API-DMAC10.html)
JP (1) JP6122548B2 (cg-RX-API-DMAC10.html)
KR (1) KR101736416B1 (cg-RX-API-DMAC10.html)
CN (1) CN105683152B (cg-RX-API-DMAC10.html)
AP (1) AP2016009079A0 (cg-RX-API-DMAC10.html)
AU (1) AU2014324078B2 (cg-RX-API-DMAC10.html)
BR (1) BR112016005601B1 (cg-RX-API-DMAC10.html)
CA (1) CA2924356C (cg-RX-API-DMAC10.html)
DK (1) DK3046901T3 (cg-RX-API-DMAC10.html)
ES (1) ES2655455T3 (cg-RX-API-DMAC10.html)
IL (1) IL244621A (cg-RX-API-DMAC10.html)
MX (1) MX368865B (cg-RX-API-DMAC10.html)
MY (1) MY172557A (cg-RX-API-DMAC10.html)
NO (1) NO3046901T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ717927A (cg-RX-API-DMAC10.html)
PH (1) PH12016500497B1 (cg-RX-API-DMAC10.html)
PL (1) PL3046901T3 (cg-RX-API-DMAC10.html)
RU (1) RU2635564C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201601642WA (cg-RX-API-DMAC10.html)
UA (1) UA118111C2 (cg-RX-API-DMAC10.html)
WO (1) WO2015039173A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3284981B2 (ja) 1998-11-02 2002-05-27 株式会社デンソー 車両用交流発電機およびそのステータの製造方法
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
SG11201707561RA (en) * 2015-03-18 2017-10-30 Vectus Biosystems Ltd Compositions for the treatment of fibrosis and fibrosis-related conditions
NZ736165A (en) * 2015-03-18 2022-07-01 Vectus Biosystems Ltd Compositions for the treatment of kidney and/or liver disease
EP3353147B1 (en) * 2015-09-22 2021-01-13 Vectus Biosystems Limited Synthesis of terphenyl compounds
CN120114438A (zh) * 2016-04-13 2025-06-10 内布拉斯加大学董事会 施用树脂毒素的方法和用树脂毒素治疗心血管疾病的方法
BR112019001510B1 (pt) 2016-07-28 2022-11-08 Vectus Biosystems Limited Composto, e, uso de um composto para manufatura de um medicamento para tratar profilática ou terapeuticamente fibrose pulmonar, ou uma enfermidade relacionada em um indivíduo com fibrose pulmonar ou em risco de desenvolver fibrose pulmonar

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694288B1 (fr) * 1992-06-30 1994-09-09 Rhone Poulenc Agrochimie Phenylbenzamides fongicides et procédés pour les préparer.
EP1768689B1 (en) * 2004-06-11 2014-08-20 Vectus Biosystems Limited Compositions and methods for treatment of cardiovascular disease
AU2006322656B2 (en) * 2005-12-09 2012-03-08 Vectus Biosystems Limited VIP fragments and methods of use
US20120088737A2 (en) * 2009-10-02 2012-04-12 Ajinomoto Co., Inc Novel acyl guanidine derivatives
US9630935B2 (en) * 2013-09-17 2017-04-25 Vectus Biosystems Limited Compositions for the treatment of hypertension and/or fibrosis

Also Published As

Publication number Publication date
PL3046901T3 (pl) 2018-03-30
RU2016112257A (ru) 2017-10-20
MX2016003371A (es) 2016-10-21
MY172557A (en) 2019-12-02
CA2924356C (en) 2018-04-03
UA118111C2 (uk) 2018-11-26
IL244621A0 (en) 2016-04-21
MX368865B (es) 2019-08-02
KR20160074471A (ko) 2016-06-28
KR101736416B1 (ko) 2017-05-16
SG11201601642WA (en) 2016-04-28
JP2016532632A (ja) 2016-10-20
AP2016009079A0 (en) 2016-03-31
ES2655455T3 (es) 2018-02-20
NZ717927A (en) 2018-12-21
BR112016005601A8 (pt) 2020-02-18
NO3046901T3 (cg-RX-API-DMAC10.html) 2018-03-17
DK3046901T3 (en) 2018-01-02
IL244621A (en) 2017-04-30
PH12016500497A1 (en) 2016-06-13
RU2635564C2 (ru) 2017-11-14
JP6122548B2 (ja) 2017-04-26
WO2015039173A1 (en) 2015-03-26
CN105683152B (zh) 2017-03-22
CN105683152A (zh) 2016-06-15
AU2014324078B2 (en) 2016-12-15
EP3046901A1 (en) 2016-07-27
CA2924356A1 (en) 2015-03-26
US20160221933A1 (en) 2016-08-04
EP3046901B1 (en) 2017-10-18
US9458093B2 (en) 2016-10-04
AU2014324078A1 (en) 2016-04-07
BR112016005601B1 (pt) 2021-02-02
EP3046901A4 (en) 2017-04-12

Similar Documents

Publication Publication Date Title
CA2924356C (en) Compositions for the treatment of hypertension and/or fibrosis
US20250195526A1 (en) Pharmaceutical compositions comprising sepiapterin and uses thereof
EA021974B1 (ru) Противовирусное соединение
EP3680232B1 (en) Novel anthranilic acid-based compound, and pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same
CA2924353C (en) Compositions for the treatment of hypertension and/or fibrosis
KR20040031702A (ko) 키마제 저해제 및 ace 저해제를 유효성분으로 함유하는약제
WO2017189613A1 (en) Methods of using fasn inhibitors
US9181248B2 (en) [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors
EP3680233A1 (en) NOVEL AMIDE COMPOUND, AND Pin1 INHIBITOR, THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES AND THERAPEUTIC AGENT FOR CANCER THAT USE THE SAME
RU2056416C1 (ru) Производные тиомочевины, фармацевтическая композиция и способ лечения
CN105085594A (zh) N6-(1-(4-甲氧基苯基)乙基)-腺苷的制备及用途
HK1226324A1 (en) Compositions for the treatment of hypertension and/or fibrosis
HK1226324B (en) Compositions for the treatment of hypertension and/or fibrosis
CN117915917A (zh) 使用sGC刺激剂的CNS疾病治疗
US10183908B2 (en) Compositions for the treatment of kidney and/or liver disease
JPWO2014030624A1 (ja) スチルベン誘導体を有効成分として含有する筋緊張性ジストロフィー治療剤
JP2019089720A (ja) 化合物又はその薬学的に許容され得る塩、筋形成促進剤、筋萎縮抑制剤、医薬組成物及びtaz活性化剤
HK1230159B (en) Compositions for the treatment of hypertension and/or fibrosis
HK1248212B (en) Compositions for the treatment of kidney and/or liver disease
HK1248212A1 (en) Compositions for the treatment of kidney and/or liver disease
CN103159650A (zh) 芳香杂环磺酰胺类化合物的制备及其应用